文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

英国伦敦三家性健康诊所中男男性行为者对HIV暴露前预防的感知需求及兴趣

Perceived need of, and interest in, HIV pre-exposure prophylaxis amongst men who have sex with men attending three sexual health clinics in London, UK.

作者信息

Bull Lauren, Dimitrijevic Pavle, Beverley Sophie, Scarborough Alex, Mandalia Sundhiya, Dosekun Olamide, Barber Tristan, Reeves Iain, McCormack Sheena, Rayment Michael

机构信息

1 Chelsea and Westminster Hospital, London, UK.

2 Imperial College Healthcare NHS trust, London, UK.

出版信息

Int J STD AIDS. 2018 Apr;29(5):435-442. doi: 10.1177/0956462417730259. Epub 2017 Sep 20.


DOI:10.1177/0956462417730259
PMID:28927341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5975944/
Abstract

HIV pre-exposure prophylaxis (PrEP) has proven efficacy in reducing the risk of HIV infection in men who have sex with men (MSM), but has not yet been commissioned in the UK. The aim of this study was to investigate perceived need and benefit (or experience of) PrEP among HIV-negative MSM attending sexual health clinics. HIV-negative MSM attending three sexual health centres in London, UK were opportunistically invited to complete a questionnaire. Data collected comprised demographic data and sexual and drug use behaviours as well as questions regarding perceptions of risk and need for PrEP. Logistic regression analysis was undertaken to identify variables predicting acceptability of, and intention to use, PrEP. In addition, data were gathered in respondents already taking PrEP. Eight hundred and thirty-nine questionnaires were analysed. The median age of respondents was 35 years (IQR 28-41, range 18-78), 650 (77%) were of white ethnicity and 649 (77%) had a university education. Four hundred and fifty-six (54%) reported at least one episode of condomless anal sex in the preceding three months, 437 (52%) reported recreational drug use in the preceding three months and 311 (37%) had been diagnosed with a sexually transmitted infection within the preceding six months. Four hundred and sixty-three (64%) of 726 strongly agreed with the statement 'I think I would benefit from PrEP'. Multivariate logistic regression analysis demonstrated that having receptive anal intercourse (RAI) without condoms, having an awareness of the risk of unprotected RAI and having belief in the effectiveness of PrEP were independent predictors for someone thinking they would benefit from taking PrEP. Eight percent of respondents (59/724) had already taken or were currently taking PrEP. The results suggest that individuals at risk are likely to perceive themselves as benefiting from PrEP. The majority perceived their risk of acquiring HIV and benefit from PrEP accurately. Overall they appeared to have little concern over the use of PrEP and generally positive attitudes. Further investigation is warranted to understand why those at risk do not perceive benefit from PrEP.

摘要

艾滋病毒暴露前预防(PrEP)已被证明在降低男男性行为者(MSM)感染艾滋病毒的风险方面具有疗效,但在英国尚未得到推广。本研究的目的是调查在性健康诊所就诊的艾滋病毒阴性男男性行为者对PrEP的感知需求和益处(或使用体验)。在英国伦敦的三个性健康中心就诊的艾滋病毒阴性男男性行为者被机会性地邀请填写一份问卷。收集的数据包括人口统计学数据、性和药物使用行为,以及关于风险感知和PrEP需求的问题。进行逻辑回归分析以确定预测PrEP可接受性和使用意愿的变量。此外,还收集了已经在服用PrEP的受访者的数据。对839份问卷进行了分析。受访者的中位年龄为35岁(四分位间距28 - 41,范围18 - 78),650人(77%)为白人,649人(77%)拥有大学学历。456人(54%)报告在过去三个月中至少有一次无保护肛交,437人(52%)报告在过去三个月中使用过娱乐性药物,311人(37%)在过去六个月内被诊断患有性传播感染。在726名受访者中,463人(64%)强烈同意“我认为我将从PrEP中受益”这一说法。多变量逻辑回归分析表明,有无保护的接受肛交(RAI)、意识到无保护RAI的风险以及相信PrEP的有效性是认为自己会从服用PrEP中受益的独立预测因素。8%的受访者(59/724)已经服用或正在服用PrEP。结果表明,有风险的个体可能认为自己会从PrEP中受益。大多数人准确地感知到自己感染艾滋病毒的风险以及从PrEP中获得的益处。总体而言,他们似乎对PrEP的使用不太担心,态度普遍积极。有必要进一步调查,以了解为什么有风险的人没有意识到从PrEP中获得的益处。

相似文献

[1]
Perceived need of, and interest in, HIV pre-exposure prophylaxis amongst men who have sex with men attending three sexual health clinics in London, UK.

Int J STD AIDS. 2018-4

[2]
Who Will Use Pre-Exposure Prophylaxis (PrEP) and Why?: Understanding PrEP Awareness and Acceptability amongst Men Who Have Sex with Men in the UK--A Mixed Methods Study.

PLoS One. 2016-4-19

[3]
Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013-2016.

Sex Transm Infect. 2018-4-26

[4]
Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study.

Lancet Public Health. 2020-9

[5]
Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.

AIDS Behav. 2016-12

[6]
Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin.

BMC Public Health. 2020-8-20

[7]
Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.

AIDS Care. 2016

[8]
A structural equation model to predict pre-exposure prophylaxis acceptability in men who have sex with men in Leicester, UK.

HIV Med. 2018-8-30

[9]
Does HIV Pre-Exposure Prophylaxis Modify the Effect of Partnership Characteristics on Condom Use? A Cross-Sectional Study of Sexual Partnerships Among Men Who Have Sex with Men in San Francisco, California.

AIDS Patient Care STDS. 2019-4

[10]
High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.

J Int AIDS Soc. 2019-9

引用本文的文献

[1]
Social and sexual networks of newly diagnosed people living with HIV: a qualitative social network analysis.

BMC Public Health. 2025-2-15

[2]
Predictors of Human Immunodeficiency Virus Pre-Exposure Prophylaxis (PrEP) Uptake in a Sexual Health Clinic With Rapid PrEP Initiation.

Open Forum Infect Dis. 2023-2-8

[3]
PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future.

Vaccines (Basel). 2023-1-4

[4]
Interest in Taking HIV Pre-exposure Prophylaxis Is Associated with Behavioral Risk Indicators and Self-Perceived HIV Risk Among Men Who Have Sex with Men Attending HIV Testing Venues in Sweden.

Arch Sex Behav. 2020-6-3

[5]
Patterns of sexualised recreational drug use and its association with risk behaviours and sexual health outcomes in men who have sex with men in London, UK: a comparison of cross-sectional studies conducted in 2013 and 2016.

Sex Transm Infect. 2019-11-19

[6]
Combination prevention and HIV: a cross-sectional community survey of gay and bisexual men in London, October to December 2016.

Euro Surveill. 2019-6

[7]
How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP.

J Virus Erad. 2018-10-1

[8]
A structural equation model to predict pre-exposure prophylaxis acceptability in men who have sex with men in Leicester, UK.

HIV Med. 2018-8-30

本文引用的文献

[1]
HIV incidence in an open national cohort of men who have sex with men attending sexually transmitted infection clinics in England.

HIV Med. 2017-1-27

[2]
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis.

Trials. 2016-3-24

[3]
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

N Engl J Med. 2015-12-1

[4]
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Lancet. 2016-1-2

[5]
High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.

J Acquir Immune Defic Syndr. 2015-4-1

[6]
WHO 'Treatment as Prevention' guidelines are unlikely to decrease HIV transmission in the UK unless undiagnosed HIV infections are reduced.

AIDS. 2014-1-14

[7]
How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention.

AIDS Behav. 2014-2

[8]
The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies.

PLoS Med. 2013-3-12

[9]
FDA paves the way for pre-exposure HIV prophylaxis.

Lancet. 2012-7-28

[10]
HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention.

PLoS Med. 2012-7-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索